U.S. Food and Drug Administration
Topic Paragraphs
Featured Topics
FDA.gov Website Refresh
FDA is pleased to announce the launch of our newly redesigned public website. We are making website improvements to provide a more modern and customer-centric web experience.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
May 24
FDA approves innovative gene therapy to treat pediatric patients with spinal muscular atrophy, a rare disease and leading genetic cause of infant mortality
May 23
FDA alerts hospitals, laboratories and health care professionals about recall of Beckman Coulter blood test analyzers due to risk of inaccurate platelet analyzing results
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
May 23
Pharm D Solutions, LLC Issues Voluntary Nationwide Recall of All Sterile Compounded Drugs Due to a Potential Lack of Sterility Assurance
May 22
House of Spices (India) Issues Allergy Alert on Undeclared Sulfites in "Laxmi Dried Apricot"
Food & Beverages
May 22
In Association with ADM Milling Co., ALDI Issues Isolated Recall for 5 lb. Bakers Corner All Purpose Flour
Food & Beverages
FDA Voices: Perspectives from FDA Experts
Working with the Food Industry to Reduce Confusion Over Date Labels
"Best If Used By" helps clarify that the date label is about quality, not safety, and that products do not necessarily have to be discarded after the date.
FDA’s Global Inspection Program Helps Ensure Generic Drug Safety
FDA stands behind the rigorous standards and regulatory inspections that go into ensuring the safety and quality of all generic drugs.
FDA's Generic Drug Priorities: Safety, Efficacy, and Expanded Access
The agency continues to work to ensure a supply of safe, effective, and cost-saving generic drugs, each manufactured under our rigorous quality standards.
Recently Published Guidances
May 24
Section 503A Bulks List Final Rule Questions and Answers; Small Entity Compliance Guide;
Drugs
May 21
Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment and Other Quality-Related Considerations Guidance for Industry
Drugs
May 17
Draft Guidance for Industry: The Use of an Alternate Name for Potassium Chloride in Food Labeling
Food & Beverages